PFIZER INC Annual Revenue from Contract with Customer, Excluding Assessed Tax in USD from 2016 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Pfizer Inc annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2016 to 2023.
- Pfizer Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending December 31, 2022 was $15.8B, a 2.68% decline year-over-year.
- Pfizer Inc Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending December 31, 2022 was $91.8B, a 24.7% increase year-over-year.
- Pfizer Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $50.9B, a 44.5% decline from 2022.
- Pfizer Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $91.8B, a 24.7% increase from 2021.
- Pfizer Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $73.6B, a 76.8% increase from 2020.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Growth (%)